Marinus Pharmaceuticals to Participate in Canaccord Genuity Rare Disease Biopharma Day
January 27, 2015Marinus Pharmaceuticals will participate in the Canaccord Genuity 2015 Rare Disease, BioPharma One-on-One Day on Tuesday, February 3, 2015 at the Omni Berkshire Place in New York. Here, Marinus will have the opportunity to connect with key investors in t
More »
Alimera Sciences' ILUVIEN® Receives Marketing Authorization in Finland and Luxembourg
January 26, 2015Alimera Sciences received marketing authorization for ILUVIEN® in Finland and Luxembourg. ILUVIEN® treats vision impairment associated with chronic diabetic macular edema that is unresponsive to available therapies.
More »
Aldeyra Therapeutics Announces $2.0 Million Private Placement
January 20, 2015Aldeyra Therapeutics enters into a definitive purchase agreement with a leading financial services company to raise approximately $2M in a private placement. Proceeds will go to its Phase 2 clinical trials, working capital, and general corporate purposes.
More »